A phase 1/2 of TRX518 in combination with Avelumab and chemotherapy.
Phase of Trial: Phase I/II
Latest Information Update: 27 Jul 2018
At a glance
- Drugs Avelumab (Primary) ; TRX 518 (Primary) ; Cyclophosphamide
- Indications Breast cancer; Ovarian cancer; Prostate cancer; Solid tumours
- Focus Therapeutic Use
- Sponsors Leap Therapeutics
- 27 Jul 2018 New trial record
- 23 Jul 2018 According to a Leap Therapeutics media release, the company has entered into a collaboration agreement with Merck KGaA and Pfizer to evaluate TRX518 in combination with Avelumab and chemotherapy
- 23 Jul 2018 According to a Leap Therapeutics media release, the study is expected to begin enrolling patients in the first quarter of 2019.